Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients.
chronic kidney disease
end-stage renal disease
max flow rate
uroflowmetry
urological disorders
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
24
01
2018
entrez:
15
6
2019
pubmed:
15
6
2019
medline:
15
6
2019
Statut:
epublish
Résumé
Chronic kidney disease (CKD) is a highly prevalent condition. Urologic disorders are known causes of CKD, but often remain undiagnosed and underestimated also for their insidious onset and slow progression. We aimed to evaluate the prevalence of urological unrecognized diseases in CKD patients by uroflowmetry. We enrolled consecutive stable CKD outpatients. The patients carried out two questionnaires, the International Prostate Symptom Score and Incontinence Questionnaire-Short Form, and they also underwent uroflowmetry, evaluating max flow rate ( A total of 83 patients (43 males, mean age of 59.8 ± 13.3 years) were enrolled. Our study showed 28 males and 10 females with a significant reduction of We showed an elevated prevalence of urological diseases in nephropathic patients; therefore, we suggest to include uroflowmetry in CKD patient assessment, considering the non-invasiveness, repeatability and low cost of examination. Uroflowmetry could be used to identify previously unrecognized urological diseases, which may prevent the onset of CKD or progression to end-stage renal disease and reduce the costs of management.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic kidney disease (CKD) is a highly prevalent condition. Urologic disorders are known causes of CKD, but often remain undiagnosed and underestimated also for their insidious onset and slow progression. We aimed to evaluate the prevalence of urological unrecognized diseases in CKD patients by uroflowmetry.
METHODS
METHODS
We enrolled consecutive stable CKD outpatients. The patients carried out two questionnaires, the International Prostate Symptom Score and Incontinence Questionnaire-Short Form, and they also underwent uroflowmetry, evaluating max flow rate (
RESULTS
RESULTS
A total of 83 patients (43 males, mean age of 59.8 ± 13.3 years) were enrolled. Our study showed 28 males and 10 females with a significant reduction of
CONCLUSIONS
CONCLUSIONS
We showed an elevated prevalence of urological diseases in nephropathic patients; therefore, we suggest to include uroflowmetry in CKD patient assessment, considering the non-invasiveness, repeatability and low cost of examination. Uroflowmetry could be used to identify previously unrecognized urological diseases, which may prevent the onset of CKD or progression to end-stage renal disease and reduce the costs of management.
Identifiants
pubmed: 31198542
doi: 10.1093/ckj/sfy085
pii: sfy085
pmc: PMC6543956
doi:
Types de publication
Journal Article
Langues
eng
Pagination
414-419Références
J Urol. 2000 Nov;164(5):1490-3
pubmed: 11025689
BJU Int. 2001 Apr;87(6):581-4
pubmed: 11298062
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S37-40
pubmed: 11792760
J Urol. 1992 Nov;148(5):1549-57; discussion 1564
pubmed: 1279218
BMJ. 2004 Mar 13;328(7440):634-40
pubmed: 15016698
Neurourol Urodyn. 2004;23(4):322-30
pubmed: 15227649
BJU Int. 2006 Jan;97(1):101-8
pubmed: 16336337
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Nihon Ronen Igakkai Zasshi. 2006 Jul;43(4):498-504
pubmed: 16937943
Rev Urol. 2004;6 Suppl 1:S32-7
pubmed: 16985853
Rev Urol. 2005;7 Suppl 6:S14-21
pubmed: 16986024
Pediatr Nephrol. 2007 Dec;22(12):1999-2009
pubmed: 17310363
BJU Int. 2010 May;105(10):1424-8
pubmed: 19874305
Ther Adv Urol. 2010 Oct;2(5-06):187-94
pubmed: 21789074
G Ital Nefrol. 2011 Jul-Aug;28(4):401-7
pubmed: 21809309
J Urol. 2011 Oct;186(4):1460-6
pubmed: 21855938
Pediatr Nephrol. 2014 May;29(5):779-92
pubmed: 23471475
Diabetes Res Clin Pract. 2015 Jul;109(1):164-9
pubmed: 25979274
Lancet Neurol. 2015 Jul;14(7):720-32
pubmed: 26067125
Korean J Urol. 2015 Dec;56(12):803-10
pubmed: 26682020
J Renal Inj Prev. 2015 Nov 30;4(4):120-6
pubmed: 26693499
Can Urol Assoc J. 2017 Mar-Apr;11(3-4):E83-E87
pubmed: 28360952
J Urol. 1981 Aug;126(2):205-9
pubmed: 7196460
J Urol. 1993 Nov;150(5 Pt 2):1706-8; discussion 1708-9
pubmed: 7692106
Eur Urol. 1997;31(2):129-40
pubmed: 9076454